Clinical Trials Logo

Ileostomy clinical trials

View clinical trials related to Ileostomy.

Filter by:

NCT ID: NCT05915052 Completed - Ileostomy Clinical Trials

B-suture Ileostomy in Clinical Practice: a Retrospective, Single-center, Propensity Score-matched Study

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

OBJECTIVE: The purpose of this study was to introduce a new temporary ileostomy modality, the B-suture ileostomy, and to compare its technical advantages in comparison with conventional ileostomy. CONCLUSION: This study shows that B-suture ileostomy can simplify the surgical procedure, facilitate learning and promotion, shorten the stoma and surgical time, can reduce complications such as irritant dermatitis, peristoma infection, stoma stricture, stoma retraction, shorten the hospital stay, reduce postoperative pain, and is similar to the traditional procedure in terms of secondary surgical return, which is a surgical procedure worth continuing to explore.

NCT ID: NCT05457660 Recruiting - Colostomy Clinical Trials

Transverse Study About QOL for Colostomized or Ileostomized Patients During Their Home Hospitalization

STOM'HAD
Start date: February 15, 2022
Phase:
Study type: Observational

The goalf of the study is to have a basis about QOL for colo-stoma and ileo-stoma for patients which are hospitalized at home. The QOL measurement is done with a questionnaire of several items made by stomatherapist and also using EQ5D QOL form. After reviewing of the data, our goal is to create or improve some solutions to improve their QOL during their home hospitalization.

NCT ID: NCT04372992 Terminated - Rectal Cancer Clinical Trials

The Stoma Closure Before or After Adjuvant Therapy Trial

STOMAD
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

This is an open-label multicenter controlled trial, including 28 centers from the Rete Oncologica (Oncological Network) of Piemonte and Valle d'Aosta in Italy (http://www.reteoncologica.it). After a curative resection for rectal cancer and temporary ileostomy, 270 patients with indication to adjuvant chemotherapy will be randomized to early (before starting adjuvant treatment) or late (after adjuvant treatment completion) stoma closure. Primary end point will the compliance to adjuvant therapy. Secondary endpoint will include quality of life and bowel function evaluation, postoperative morbidity, chemotherapy toxicity, oncological outcomes and costs comparison.

NCT ID: NCT03909542 Completed - Clinical trials for Inflammatory Bowel Diseases

Malnutrition Associated With Complications After Ileostomy Reversal

Start date: March 2015
Phase:
Study type: Observational

An ileostomy is a surgical opening established by bringing the end or a loop of the ileum to discharge directly outside the body. This is typically done when part or the entire colon is removed because of IBD, cancer, or familial adenomatous polyposis. Reversal of this procedure, an ileostomy closure, may be done if possible. Ileostomy closure involves reconnecting the ileum to the remaining colon, allowing normal bowel movements again. This study will look at the outcomes of these surgeries in patients who were seen and operated on by the investigators.

NCT ID: NCT02675634 Completed - Ileostomy Clinical Trials

Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy

Start date: January 2016
Phase: N/A
Study type: Interventional

This clinical investigation is intended to explore the performance and safety of two newly developed ostomy products with regard to the products fit to body properties.

NCT ID: NCT02658123 Terminated - Ileostomy Clinical Trials

Reducing Readmissions in High-Risk Ostomates

Start date: April 2016
Phase: N/A
Study type: Interventional

Preventing complications and readmission after ostomy surgery will decrease the cost of healthcare, improve patient safety, reduce the cost of durable medical equipment required by ostomates, ensure continued specialized care is available, and potentially improve both short and long-term quality of life (QOL) for patients by reducing morbidity and mortality associated with ostomy surgery. The purpose of this study is to measure the effectiveness of patient centered interventions/care pathways and to determine the impact on healthcare utilization, 30-day hospital readmissions, and QOL.

NCT ID: NCT02626260 Completed - Ileostomy Clinical Trials

A Pilot Evaluation of Adhesives and How They Are Impacted by Output

Start date: November 2015
Phase: N/A
Study type: Interventional

The study investigates the impact real output has on the adhesion of adhesives.

NCT ID: NCT02610907 Completed - Ileostomy Clinical Trials

A Pilot Evaluation of Adhesives and How They Are Impacted by Out-put

Start date: November 2015
Phase: N/A
Study type: Interventional

The study investigates the impact real output (subjects own) and simulated output have on the adhesion of adhesives.

NCT ID: NCT02594085 Completed - Ileostomy Clinical Trials

An Exploratory Study Investigating Adhesive Reaction to Output

Start date: October 2015
Phase: N/A
Study type: Interventional

The objective is to investigate the impact that faecal output has on adhesives.

NCT ID: NCT02543190 Completed - Colorectal Surgery Clinical Trials

System-Wide Improvement for Transitions After Surgery: The SWIFT Post op Program

SWIFT
Start date: October 2014
Phase: N/A
Study type: Interventional

Short-term post-operative complications after colon and rectal surgery present a known major clinical and financial burden for patients and hospitals. Focused efforts to reduce readmissions after colorectal surgery is one potentially high-yield and broad approach to address this problem since post- operative complications are the strongest predictor of readmissions. We focus on decreasing readmissions after ileostomy surgery by using a previously published intervention that prevents dehydration in the outpatient setting and decreases acute renal failure complications. We plan to introduce the SWIFT post op program for ileostomy patients at one academic and two community hospitals which are part of a single health care system, and to then randomize patients to usual care in the setting of this new program versus an aggressive compliance surveillance and improvement strategy (CSIS) strategy using study personnel. Our primary study outcome is all-cause 30-day readmission, and our secondary outcomes include patient satisfaction (CAHPS scores) and a cost-benefit analysis. We seek to create a partnership between colorectal surgeons, inpatient nurse managers and wound ostomy continence nurses (WOCN) at the three sites, linking them with outpatient nurse practitioners and physician's assistants at the respective colorectal surgery clinics who facilitate care-transition after hospital discharge.